HSD17B11 anticorps (AA 20-300) (FITC)

N° du produit ABIN7152035

Détail du produit anti-HSD17B11 anticorps (FITC)

Antigène: HSD17B11 (Hydroxysteroid (17-Beta) Dehydrogenase 11 (HSD17B11))

Épitope: AA 20-300

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp HSD17B11 est conjugé à/à la FITC

Application: Veuillez nous consulter SVP

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Estradiol 17-beta-dehydrogenase 11 protein (20-300AA)

Isotype: IgG

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur HSD17B11

Antigène: HSD17B11 (Hydroxysteroid (17-Beta) Dehydrogenase 11 (HSD17B11))

Autre désignation: HSD17B11 (HSD17B11 Produits)

Synonymes: anticorps 17BHSD11, anticorps DHRS8, anticorps PAN1B, anticorps RETSDR2, anticorps SDR16C2, anticorps Dhrs8, anticorps HSD17B13, anticorps MGC84756, anticorps HSD17B11, anticorps Pan1b, anticorps SDR2, anticorps retSDR2, anticorps 17-beta-HSD 11, anticorps 17-beta-HSD XI, anticorps 17bHSD11, anticorps 17betaHSD11, anticorps 17betaHSDXI, anticorps hydroxysteroid 17-beta dehydrogenase 11, anticorps hydroxysteroid (17-beta) dehydrogenase 11, anticorps hydroxysteroid (17-beta) dehydrogenase 11 L homeolog, anticorps estradiol 17-beta-dehydrogenase 11, anticorps HSD17B11, anticorps Hsd17b11, anticorps hsd17b11.L, anticorps hsd17b11, anticorps LOC100348005, anticorps LOC100520923

Sujet:

Background: Can convert androstan-3-alpha,17-beta-diol (3-alpha-diol) to androsterone in vitro, suggesting that it may participate in androgen metabolism during steroidogenesis. May act by metabolizing compounds that stimulate steroid synthesis and/or by generating metabolites that inhibit it. Has no activity toward DHEA (dehydroepiandrosterone), or A-dione (4-androste-3,17-dione), and only a slight activity toward testosterone to A-dione. Tumor-associated antigen in cutaneous T-cell lymphoma.

Aliases: 17 beta HSD 11 antibody, 17 beta HSD XI antibody, 17 BETA HSD11 antibody, 17 BETA HSDXI antibody, 17 beta hydroxysteroid dehydrogenase 11 antibody, 17 beta hydroxysteroid dehydrogenase type XI antibody, 17 beta hydroxysteroid dehydrogenase XI antibody, 17-beta-HSD 11 antibody, 17-beta-HSD XI antibody, 17-beta-hydroxysteroid dehydrogenase 11 antibody, 17-beta-hydroxysteroid dehydrogenase XI antibody, 17betaHSD11 antibody, 17betaHSDXI antibody, 17bHSD11 antibody, CTCL associated antigen HD CL 03 antibody, CTCL tumor antigen HD CL 03 antibody, CTCL-associated antigen HD-CL-03 antibody, Cutaneous T cell lymphoma associated antigen HD CL 03 antibody, Cutaneous T-cell lymphoma-associated antigen HD-CL-03 antibody, Dehydrogenase/reductase SDR family member 8 antibody, DHB11_HUMAN antibody, DHRS8 antibody, Estradiol 17 beta dehydrogenase 11 antibody, Estradiol 17-beta-dehydrogenase 11 antibody, Hsd17b11 antibody, Hydroxysteroid (17 beta) dehydrogenase 11 antibody, PAN1B antibody, Retinal short chain dehydrogenase/reductase 2 antibody, Retinal short-chain dehydrogenase/reductase 2 antibody, RETSDR2 antibody, SDR16C2 antibody, SDR2 antibody, Short chain dehydrogenase/reductase family 16C member 2 antibody, T cell lymphoma associated antigen HD CL 03 antibody

UniProt: Q8NBQ5